Small Molecule Pharmaceuticals

 
 
Request Information

High-Quality Products and Services for Small Molecules


Developing a new pharmaceutical drug is a complex and challenging process. As the leader in high-quality products and services for the chemical and pharmaceutical industries, we offer everything you need to optimize development and reduce time to market for your therapeutic small molecules.

And with our comprehensive EMPROVE® dossiers we provide detailed, usage-specific documentation for more than 400 pharma raw materials that includes information on manufacturing, test methods, purity and stability data, helping you to successfully navigate regulatory challenges to the release of your small molecules.
  • A continually updated portfolio for evolving markets and regulatory requirements
  • A wide range of customer-centric services
  • Tailor-made production quantities on a global scale
  • Expertise and state-of-the-art equipment backed by a complete matrix of production technologies capable of fulfilling more than 95% of all common chemical reactions
  • Full service throughout the entire development chain supporting you in chemical as well as regulatory aspects
  • cGMP-certified and FDA-inspected development and production sites

News Releases

Apr 18, 2018
MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation

MilliporeSigma today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Apr 17, 2018
MilliporeSigma Introduces New Single-use Technologies to Advance Flexible Manufacturing

MilliporeSigma today introduced three new products to support flexible manufacturing of biologics.

20180417
Apr 12, 2018
MilliporeSigma Helps Accelerate Global Access to Affordable Vaccines

MilliporeSigma today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 28, 2018
MilliporeSigma Named Best Bioprocessing Supplier in Asia

MilliporeSigma was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Mar 05, 2018
MilliporeSigma and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

MilliporeSigma and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 27, 2018
MilliporeSigma Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

MilliporeSigma today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 26, 2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Announces Investment in India with New Life Science Manufacturing & Distribution Centre

MilliporeSigma today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

MilliporeSigma today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 22, 2018
MilliporeSigma Accelerates Mobius® Single-Use Manufacturing in Wuxi

MilliporeSigma today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 20, 2018
MilliporeSigma Receives Two More Patents for CRISPR Technology

MilliporeSigma today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting MilliporeSigma’s patent applications for the company’s CRISPR technology.

20180220 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
Feb 13, 2018
MilliporeSigma Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

MilliporeSigma today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
View All News
 
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies

Webinar:
Successful Drug Development with Synthetic Lipids:
Critical Aspects and
Strategies

Watch Now
Webinar: Smart Labels - Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Webinar:
Smart Labels – Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Watch Now
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!

Events